By G HossainPosted on January 14, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs After a period of diversification, Novo Nordisk is returning to its roots by focusing on the 2 billion people with diabetes, obesity or overweight. JPM26: Novo Refocuses on Diabetes and Obesity Amid Push To Expand GLP-1 Market Post navigation JPM26: Lilly Plots Path to Dominance as Obesity Market Enters a New EraTrump Must Make Biotech Innovation a National Priority